secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001193125-23-143456
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica restates FY2022 financials due to errors in convertible note and warrant valuation
--------------------------------------------------------------------------------

- Board concluded Dec 31, 2022 financial statements should no longer be relied upon.
- Errors in valuation of convertible promissory notes and warrant liability; models did not consider merger conversion formula.
- Restatement expected to decrease carrying value of notes and warrant liability, reduce net loss and net loss per share.
- Company plans to file an amended report to reflect corrections; subject to completion of Ernst & Young audit.
- Previously furnished/filed reports describing financial results from Original Report should no longer be relied upon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523143456/0001193125-23-143456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523143456/d491121d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-143456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer